Hassan Manal M, Hwang Lu-Yu, Hatten Chiq J, Swaim Mark, Li Donghui, Abbruzzese James L, Beasley Palmer, Patt Yehuda Z
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780.
Risk factors associated with hepatocellular carcinoma (HCC) are well documented, but the synergisms between these risk factors are not well examined. We conducted a hospital-based, case-control study among 115 HCC patients and 230 non-liver cancer controls. Cases and controls were pathologically diagnosed at The University of Texas M. D. Anderson Cancer Center and were matched by 5-year age groups, sex, and year of diagnosis. Information on risk factors was collected by personal interview and medical records review. Blood samples were tested for the presence of antibodies to hepatitis C virus antigen (anti-HCV), hepatitis B surface antigen (HBsAg), and antibodies to hepatitis B core antigen (anti-HBc). Conditional logistic regression was used to determine odds ratios (ORs) by the maximum likelihood method. Multivariate ORs and 95% confidence intervals (CIs) were 15.3 (4.3-54.4), 12.6 (2.5-63.1), 4.5 (1.4-14.8), and 4.3 (1.9-9.9) for anti-HCV, HBsAg, heavy alcohol consumption (>/=80 mL ethanol/d), and diabetes mellitus, respectively. Synergistic interactions on the additive model were observed between heavy alcohol consumption and chronic hepatitis virus infection (OR, 53.9; 95% CI, 7.0-415.7) and diabetes mellitus (OR, 9.9; 95% CI, 2.5-39.3). Independent of the effect of HCV, HBV, and diabetes mellitus, heavy alcohol consumption contributes to the majority of HCC cases (32%), whereas 22%, 16%, and 20% were explained by HCV, HBV, and diabetes mellitus, respectively. In conclusion, the significant synergy between heavy alcohol consumption, hepatitis virus infection, and diabetes mellitus may suggest a common pathway for hepatocarcinogenesis. Exploring the underlying mechanisms for such synergisms may indicate new HCC prevention strategies in high-risk individuals.
与肝细胞癌(HCC)相关的风险因素已有充分记录,但这些风险因素之间的协同作用尚未得到充分研究。我们在115例HCC患者和230例非肝癌对照者中开展了一项基于医院的病例对照研究。病例和对照均在德克萨斯大学MD安德森癌症中心经病理诊断,并且按5岁年龄组、性别和诊断年份进行匹配。通过个人访谈和查阅病历收集风险因素信息。检测血样中丙型肝炎病毒抗原抗体(抗-HCV)、乙型肝炎表面抗原(HBsAg)和乙型肝炎核心抗原抗体(抗-HBc)的存在情况。采用条件逻辑回归通过最大似然法确定比值比(OR)。抗-HCV、HBsAg、大量饮酒(≥80 mL乙醇/天)和糖尿病的多变量OR及95%置信区间(CI)分别为15.3(4.3 - 54.4)、12.6(2.5 - 63.1)、4.5(1.4 - 14.8)和4.3(1.9 - 9.9)。在相加模型中观察到大量饮酒与慢性肝炎病毒感染(OR,53.9;95%CI,7.0 - 415.7)以及糖尿病(OR,9.9;95%CI,2.5 - 39.3)之间存在协同相互作用。不考虑丙型肝炎病毒、乙型肝炎病毒和糖尿病的影响,大量饮酒导致了大多数HCC病例(32%),而丙型肝炎病毒、乙型肝炎病毒和糖尿病分别导致22%、16%和20%的病例。总之,大量饮酒、肝炎病毒感染和糖尿病之间的显著协同作用可能提示肝癌发生的共同途径。探索这种协同作用的潜在机制可能为高危个体指明新的HCC预防策略。